Psoriasis PBMC

In Stock Samples

Lot Number Condition Cell Count (M) Race/Ethnicity Age Gender Country of Collection Medications Vials Price Action
77429 Psoriasis 10M Hispanic/Latino 49 Female
Skyrizi 150mg (injection) every 3 months
6 $530.00
75687 Psoriasis 50M Caucasian 21 Male
54 mg Methylphenidate (brand name Concerta), once per day in the morning. For ADHD. 5 mg guanfacine (brand name Tenex). Twice per day. Once in the morning, once at night. For ADHD. 100 mg + 250 mg (250 mg) fluvoxamine (brand name Luvox) at night. For OCD. 25 mg metorprolol, once per day at night. For tachycardia. 40 mg atomoxetine (brand name Strattera) once per day at night. For ADHD. 5 mg estradiol valerate, subcutaneous, once per week on Saturdays. Gender-affirming hormone therapy.
107 $1,109.00
74582 Psoriasis 10M Caucasian 50 Female
Losartan 50mg QD Flovent Inhaler HFA 220mcg BID Ventolin HFA 90mcg PRN Prenatal vitamins Calcium Munjaro
10 $530.00
74223 Psoriasis 50M Caucasian 64 Female
No current history of Opzelura (a JAK inhibitor) - 2024 history of Tacrolimus, UVB treatments
38 $1,109.00
73165 Psoriasis 5M Caucasian 41 Male
Concerta 76mg QD Bupropion 300mg QD Venlaxin 150mg QD
1 $530.00
72226 Psoriasis 10M African American Hispanic/Latino 27 Female
Stelara
4 $530.00
74458 Psoriasis 100M Hispanic/Latino 49 Female United States (US)
Skyrizi 150mg (injection) every 3 months
108
68235 Psoriasis 10M Caucasian 60 Female United States (US)
Ambien 10mg/QD Levothyroxine/50mcg/QD Clobetasol/PRN Hydrochlorothiazide 25mg/QD Atenolol 50mg/QD Atorvastatin 10mg/QD
3 $530.00
68630 Psoriasis 10M Caucasian 40 Male United States (US)
Taking Skyrizi for Psoriasis Escitalopram 10mg QD
3 $530.00
65463 Psoriasis 50M Hispanic/Latino 48 Male United States (US)
COSENTYX® (secukinumab) Citalopram 10mg QD
113 $1,109.00

High-Quality Psoriasis PBMC for Research

Psoriasis PBMC products are sourced from donors clinically diagnosed with Psoriasis and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies for in vitro stimulation to examine immune cell behavior implicated in psoriasis.

Product Features

  • Research Use Only (RUO), cryopreserved PBMC
  • Clinically confirmed psoriasis donors
  • Available in cell counts ranging from 5 million to 2 billion
  • Processed within 24 hours of collection
  • Stored using CryoStor® CS10 freezing media
  • IRB-approved protocols and electronic informed consent
  • Screen LeukoLot™ available prior to bulk orders

De-identified Donor Data

  • Verified Psoriasis diagnosis
  • Donor demographics: age, sex assigned at birth, race/ethnicity
  • Self-reported allergies and infectious disease history
  • Additional psoriasis-specific data available upon request

Applications

  • Biomarker discovery and validation
  • Drug screening and therapeutic development
  • Immune pathway analysis in psoriasis pathophysiology
  • Transcriptomic and proteomic profiling

Quality and Compliance

  • IRB-approved collections and protocols
  • 21 CFR Part 11 – compliant e-consent system
  • HIPAA-compliant donor data protection

Ordering & Shipping

Psoriasis PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Frequently Asked Questions

Showing 13–24 of 30 results

Do samples come with donor screening reports?

1 Answer

All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/

YES – Certificate of analysis is available upon request.

Lead times vary from ready to ship inventory to prospective studies.

International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.

We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/

You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/

NO – no minimum order requirements.

For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com

YES – Fresh leukopaks can be delivered same day in select locations. Often, leukopaks are shipped same day as collection, thus arriving next day.

Contact learnmore@sanguinebio.com for current inventory. The website states “over 150 verified-conditions from ready-to-ship to prospective collections.” View our ready to ship products: https://sanguinebio.com/products/?pro_inventory=inventory

YES – Matched samples across multiple matrices are available, including synovial fluid are available.

1 2 3
×

Ask a Question

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information